Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Asset Writedowns and Impairment (2016 - 2025)

Utah Medical Products has reported Asset Writedowns and Impairment over the past 16 years, most recently at -$28000.0 for Q4 2025.

  • Quarterly results put Asset Writedowns and Impairment at -$28000.0 for Q4 2025, down 1500.0% from a year ago — trailing twelve months through Dec 2025 was $367000.0 (up 9275.0% YoY), and the annual figure for FY2025 was $367000.0, up 9275.0%.
  • Asset Writedowns and Impairment for Q4 2025 was -$28000.0 at Utah Medical Products, down from $402000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for UTMD hit a ceiling of $402000.0 in Q3 2025 and a floor of -$28000.0 in Q4 2025.
  • Median Asset Writedowns and Impairment over the past 5 years was $2000.0 (2021), compared with a mean of $20210.5.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 500.0% in 2021 and later crashed 1500.0% in 2025.
  • Utah Medical Products' Asset Writedowns and Impairment stood at $4000.0 in 2021, then surged by 125.0% to $9000.0 in 2022, then plummeted by 122.22% to -$2000.0 in 2023, then skyrocketed by 200.0% to $2000.0 in 2024, then crashed by 1500.0% to -$28000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were -$28000.0 (Q4 2025), $402000.0 (Q3 2025), and $2000.0 (Q2 2025) per Business Quant data.